BRS Plus 123 I-MIBG Scintigraphy for MACCE in T2DM
term cardiovascular predictive value in Japanese patients with type 2 diabetes without structural heart disease. 16 We therefore tested the hypothesis that the combination of BRS and 123 I-MIBG scintigraphic findings could strengthen the predictive power for cardiovascular events.
Editorial p 49 Methods

Patient Selection
A total of 210 patients with type 2 diabetes mellitus, who were admitted to Oita University Hospital from 1998 to 2004 for blood glucose control, were recruited. Accurate follow-up data were obtained for 165 patients (79%). Type 2 diabetes mellitus was defined as a fasting plasma glucose concentration ≥126 mg/dl, a 2-h plasma glucose concentration following a 75-g oral glucose load ≥200 mg/dl, or the self-reported use of antidiabetic medication. 17 None of the patients had organic heart disease as determined by physical examination, chest X-ray, 12-lead ECG, echocardiography, and thallium-201 SPECT. Myocardial ischemia was excluded by treadmill exercise ECG testing and 201 Tl SPECT. Essential hypertension was defined as diastolic blood pressure (BP) ≥90 mmHg, systolic BP ≥140 mmHg or self-reported use of antihypertensive medication. 18 Patients treated with α-or β-adrenergic blocking agents, tricyclic antidepressants or other serotonin reuptake inhibitors, antiplatelet agents or with macroalbuminuria (≥500 mg/day) or abnormal plasma creatinine concentrations (≥1.2 mg/dl) were also excluded from the study. Dyslipidemia was defined as fasting triglycerides >200 mg/dl, or high-density lipoprotein cholesterol ≤45 mg/dl in women and ≤35 mg/dl in men. 18 Hyperuricemia was defined as uric acid >6.0 mg/dl in women or >7.0 mg/dl in men. 19 Chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) <60 ml · min -1 · 1.73 m −2 . 20 Patients with an eGFR <30 ml · min -1 · 1.73 m −2 were excluded. This investigation was conducted according to the principles expressed in the Declaration of Helsinki. Prior informed consent in terms of gathering BRS measurements was given by all patients, and the study protocol was approved by the institutional review board of Oita University.
Cardiac 123 I-MIBG Scintigraphy
Planar studies were performed at 15 min (early) and 4 h (delayed) after the injection of 111 MBq of 123 I-MIBG. Images were acquired using a rotating gamma camera equipped with a low-energy, parallel-hole, all-purpose collimator (ZLC 7500; Siemens, Munich, Germany) and the data were analyzed with computer-based analysis software (SCINTIPAC; Shimadzu, Kyoto, Japan). The anterior planar images of the early and delayed 123 I-MIBG studies were analyzed visually. To do the semiquantitative analysis, regions of interest (ROI) were drawn over the whole heart, and a 10×10-mm area over the upper mediastinum on the early and delayed planar images was used to calculate the mean heart-mediastinum (H/M) ratio. 21, 22 After correcting for the physical decay of 123 I-MIBG, the percentage WR of the tracer from the myocardium was determined for the 4-h period. The WR was calculated from the initial and delayed images using the following formula without correction for the background and the time decay of the 123 I label:
as previously reported. 21, 22 In our hospital, the normal ranges of early H/M ratio, delayed H/M ratio, and WR were set at 2.0-2.7, 2.1-2.9, and 21-30%, respectively. We obtained cutoff values of WR and delayed H/M ratio by creating a receiver-operating characteristic (ROC) curve (Figures 1A,B) . The best WR and delayed H/M ratio values with the highest sensitivity and specificity to predict the major adverse cerebral and cardiovascular events (MACCE) were 41.4% and 1.89, respectively. Therefore, we defined enhanced WR and depressed delayed H/M ratio as ≥41.4% and ≤1.89, respectively.
BRS Measurements
For BRS assessment, all subjects were studied while lying supine in a quiet room between 9:00 and 11:00 am. 7 A catheter was inserted into the right cubital vein, and arterial BP was recorded noninvasively using tonometry (Jentow-7700; Nihon Colin, Komaki, Japan). 7 Arterial BP and 12-lead ECG were monitored simultaneously. Data were stored in a PCM data recorder (RD-200T; TEAC, Tokyo, Japan). After an interval of 30 min to allow the patient to stabilize, the patient was asked to breathe at a rate of 15 breaths/min using a metronome. BRS was assessed using the phenylephrine method. 1 Phenylephrine (2-3 μg/kg) was injected over 15 s to increase systolic BP by 15-40 mmHg. BRS was calculated as the slope of the linear regression line relating the systolic BP changes to the RR interval changes. Regression lines with more than 20 data points and a correlation coefficient (r) greater than 0.8 were accepted for analysis. 1, 23 We obtained cut-off values of BRS by creating a ROC curve ( Figure 1C) . The best BRS value with the highest sensitivity and specificity to predict the MACCE was 5.63, so we defined depressed BRS as ≤5.63.
Follow-up
Most of the follow-up for patients occurred at Oita University Hospital. Information was obtained from those patients whose follow-up was performed by a general practitioner. Information about the patients who were hospitalized in other departments was also obtained. For the patients who died, the cause of death was documented with the help of the patients' family and general practitioner.
The endpoint was defined as the occurrence of MACCE, which included cardiovascular mortality, nonfatal myocardial infarction, coronary revascularization through angioplasty or bypass, stroke and congestive heart failure requiring admission. Using this combined criterion, only the first event was taken into account in the statistical analysis.
From the ROC curves, each patient was divided into 3 groups based on the "BRS-MIBG combination score" as follows: 0, patients having both preserved BRS and WR; 1, patients having either depressed BRS or enhanced WR; 2, patients having both depressed BRS and enhanced WR. Because our previous analysis revealed that enhanced WR rather than decreased H/ M ratio predicted cardiovascular events more precisely, 16 the combined assessment of BRS and WR was represented as the BRS-MIBG combination score.
Statistical Analysis
Data are presented as mean ± SD. The chi-square test was used for categorical variables, and the analysis of variance (ANOVA) test was used for continuous variables. Kaplan-Meier MACCEfree analysis was used to compare MACCE-free times among the 3 groups based on the BRS-MIBG combination score. Univariate and multivariate Cox proportional hazard regression analyses were performed to identify independent predictors of MACCE among cardiac autonomic functions. Cardiac 
Results
Patient Characteristics
The baseline characteristics of the 3 patient groups divided by BRS-MIBG combination score are presented in Table 1 . The mean age was lower in the score 0 group than in the score 1 and 2 groups (P<0.05). Females were largely included in the score 1 (P<0.0005) and 2 (P<0.001) groups than in score 0. The duration of diabetes was longer in the score 2 group than Figure 1 . Receiver-operating characteristic curve for the ability of washout rate (A), delayed heart/mediastinum ratio (B) and baroreflex sensitivity (C) to predict major adverse cerebral and cardiovascular events. AUC, area under the curve; BRS, baroreflex sensitivity; H/M, heart/mediastinum.
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in the score 0 and 1 groups (P<0.05). Systolic BP was lower in the score 0 group than in the score 1 (P<0.0005) and 2 groups (P<0.005). The heart rate was lower in the score 0 group than in the score 2 group (P<0.05). The early and delayed H/M ratios were higher in the score 0 group than in the score 1 (P<0.05) and 2 groups (P<0.0001). The WR was higher in the score 2 group than in the score 0 (P<0.0001) and 1 groups (P<0.0001). The BRS was higher in the score 0 group than in the score 1 (P<0.0001) and 2 groups (P<0.0001), and was higher in the score 1 group than in the score 2 group (P<0.01). No significant difference was observed in terms of body mass index, fasting plasma glucose, hemoglobin A1c, diastolic BP, and eGFR. There were no significant differences among the 3 groups for sex, current smokers, hypertension, dyslipidemia, or hyperuricemia. Regarding drug use, no significant differences among the 3 groups were observed in the percentage of the patients who were being treated with angiotensin II receptor blocker, angiotensin-converting enzyme inhibitor, calcium-channel blocker or statin.
Patient Outcomes
During the mean of 4.7±2.7 years (range, 3-10 years) of follow-up, 7 patients died (4.2%). Of the 7 deaths, 4 were cardiac deaths and 3 were attributed to non-cardiac causes. The all-cause mortality rate was not significantly different among the 3 BRS-MIBG combination score groups. There were no significant differences in total cardiac mortalities among the 3 groups.
Univariate and Multivariate Predictors of MACCE
During the follow-up, 19 patients presented with MACCE (11.5%). Of the 19 cases of MACCE, 4 were cardiovascular deaths, 2 were nonfatal myocardial infarctions, 4 were coronary revascularizations, 6 were strokes, and 3 were congestive heart failure ( Table 2) . MACCE occurred more frequently in the score 2 group (33.3%) than in the score 0 (3.7%, P<0.05) and 1 (12.3%, P<0.0001) groups. Results of univariate and multivariate Cox proportional hazards regression analyses of the MACCE among the cardiac autonomic functions are presented in Table 3 . The univariate analysis revealed that BRS and BRS-MIBG score were associated with MACCE. In the subsequent multivariate analysis using the factors including MI, myocardial infarction. Other abbreviations as in Table 1 .
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BRS and BRS-MIBG combination score, only BRS-MIBG combination score (HR 3.42, 95% CI 1.54-7.85, P=0.0025) independently predicted the incidence of MACCE by multivariate analysis ( Table 3) . Figure 2 shows the MACCE-free ratio as evaluated by Kaplan-Meier analysis based on the BRS-MIBG combination score, demonstrating the significant statistical difference among the 3 groups (log-rank 16.41, P=0.0003). The comparative analysis revealed that the MACCE-free ratio was significantly lower in the score 2 group than in the score 0 group (log-rank 14.9, P=0.0001).
Kaplan-Meier MACCE-Free Estimation
Discussion
In the present study, 165 Japanese type 2 diabetic patients were followed for a mean period of 4.7 years, and MACCE occurred in 19 patients. The most important finding is that the BRS-MIBG combination score, which is combined BRS and 123 I-MIBG scintigraphic findings (WR), accurately predicted MACCE in patients with type 2 diabetes without structural heart disease/severe complications. The MACCE-free ratio as evaluated by Kaplan-Meier analysis was significantly higher in the patients with the lower BRS-MIBG combination score. Autonomic imbalance, characterized by increased sympathetic activity and/or decreased parasympathetic activity, is closely related to cardiovascular mortality. However, the relationship between cardiovascular autonomic neuropathy and the incidence of cardiovascular events has been poorly investigated in type 2 diabetic patients. In fact, there have been few Japanese reports. Previously, we suggested that the baseline assessment of BRS using the phenylephrine method might be a long-term cardiovascular predictor in type 2 diabetic patients without structural heart disease/severe complications. 23 We discussed cardiovascular autonomic neuropathy from the viewpoint of BRS, the arm of parasympathetic activity. On the other hand, we demonstrated that an abnormally increased WR of cardiac 123 I-MIBG scintigraphy at baseline had long-term cardiovascular predictive value in Japanese patients with type 2 Figure 2 . Kaplan-Meier event-free curves for major adverse cerebral and cardiovascular events among BRS-MIBG combination score 0, 1, and 2. BRS, baroreflex sensitivity.
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diabetes without structural heart disease. 16 To the best of our knowledge, this report is the first to demonstrate the combining an assessment of BRS with 123 I-MIBG scintigraphic findings strengthens the predictive power for MACCE in type 2 diabetic patients. In this study, we defined depressed BRS as ≤5.63, because we obtained the cut-off value of BRS by creating a ROC curve. The best BRS value with the highest sensitivity and specificity to predict MACCE was 5.63. In our previous study, a cutoff value <6 ms/mmHg was used to define depressed BRS, 23 because the ATRAMI study 1 categorized the post-myocardial infarction patients to 3 groups (ie, BRS <3, BRS 3.0-6.1, and BRS >6.1), which appears to be similar to our cut-off value in this study.
Cardiac autonomic neuropathy (CAN) defined by measures of abnormalities of the parasympathetic and sympathetic nervous systems is a significant cause of the morbidity and mortality associated with a high risk of cardiac arrhythmias and sudden death, possibly related to silent myocardial ischemia. Early in the natural history of diabetes there is impairment of parasympathetic function, with a relative increase of sympathetic function causing an imbalance of the sympathetic/parasympathetic tone. Later, sympathetic denervation follows, beginning at the apex of the ventricles and progressing towards the base of the heart, leading to yet another imbalance, with an increase in propensity to dysrhythmias. 24 Nagamachi et al 25 reported the prognostic value of 123 I-MIBG cardiac imaging and heart rate variability over a period of 7.2 years in 144 patients with type 2 diabetes mellitus. They demonstrated that CAN and the presence of hypertension were the best predictors for cardiac events of all of the analyzed clinical parameters. They diagnosed CAN by a combination of analyses [delayed H/M ratio <1.7 or coefficient of variation of the R-R interval <1.5]. By Kaplan-Meier analysis, the CAN-positive group had significantly lower event-free survival rates than the CAN-negative group. The combined assessment could accurately predict cardiovascular events in their study as well as ours. WR, however, could not predict cardiovascular events in the Nagamachi et al study. 25 Their patients were slightly younger, less obese, and more often women than the present patient group. One of the reasons for the differences in results might be the differences in the patients' characteristics. Cardiovascular events were associated with sex differences in cardiac autonomic function in Japanese type 2 diabetic patients without structural heart disease in a previous study. 26 Monitoring peripheral muscle sympathetic nerve activity clarified that sympathetic nerve activity is lower in young females than in age-matched males, and increases with age in both males and females, although the magnitude of the increase is greater in females than in males. It is hypothesized that an aged-dependent decline in estrogen status may shift the sympathovagal balance toward the sympathotonic direction in connection with the occurrence of cardiovascular events. 27 From these facts, it might be important to test the combination of BRS and 123 I-MIBG scintigraphic findings for the prediction of cardiovascular events.
Kasama et al showed that delta-WR ( 123 I-MIBG scintigraphy before leaving the hospital and 6 months after discharge) of less than −5% was the only incremental predictor of cardiac death by serial 123 I-MIBG studies in their multivariable analysis. 28 In this regard, we evaluated the BRS and 123 I-MIBG scintigraphic findings at baseline alone. Because glycemic control may influence diabetic autonomic dysfunction, serial BRS and cardiac 123 I-MIBG scintigraphic findings should have been evaluated.
Study Limitations
First, because we enrolled patients without severe complications, the incidence of MACCE was low, which might make it difficult to analyze the data. For instance, although the early and delayed H/M ratios were significantly higher in the low BRS-MIBG combination score patients than in the high score patients, neither of the H/M ratios predicted the incidence of MACCE. Second, some previous studies have demonstrated that abnormal myocardial perfusion SPECT can predict the risk of cardiovascular events among asymptomatic diabetic patients 1-3 years after registration. 29, 30 Therefore, it remains uncertain whether our single baseline assessment of 123 I-MIBG cardiac imaging and BRS is really enough to predict the remote development of MACCE. Finally, we analyzed the data by comparing 3 groups based on BRS-MIBG combination score. In other words, a comparison with normal "control" subjects was lacking.
Conclusions
Our results suggest that BRS assessment combined with 123 I-MIBG scintigraphic findings is much more useful for identifying type 2 diabetes patients at high risk for cardiovascular events.
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